AMCP Student Members

Student Pharmacist Center

Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
AMCP Membership
AMCP Regulatory NewsBreaks

HHS Announces Restructuring Plan

On March 27, 2025, the U.S. Department of Health and Human Services (HHS) issued a Fact Sheet: HHS’ Transformation to Make America Healthy Again. The document outlines HHS' restructuring plan as part of an initiative to enhance efficiency and address chronic diseases in America. Key changes include significant personnel reductions and consolidating divisions and offices to streamline operations.
Legislation & Regulation
AMCP Political Action Committee Logo (AMCP PAC)

AMCP Political Action Committee (AMCP PAC)

AMCP formed the PAC to support candidates who promote policies that improve the practice of managed care pharmacy. Prescription drug prices consistently rank as a top issue for voters, so it’s important to ensure that the managed care perspective is represented in these policy conversations.
Pharmacist at Pharmacy - Stock

Drug Shortages Could Surge 25% as AI Reshapes Specialty Pharmacy: Survey

A new Academy of Managed Care Pharmacy Foundation report, “Emerging Trends Impacting Managed Care Pharmacy,” developed in partnership with Pfizer, warned of significant shifts within managed care pharmacies fueled by AI adoption, drug shortages and affordability challenges.
The United States Capitol Building

Protecting Pharmacies in Medicaid Act Summary

The Protecting Pharmacies in Medicaid Act would prohibit the use of spread pricing arrangements in Medicaid programs. Pharmacy benefit managers (PBMs) would be required to pass through to pharmacies the full amount of the money paid to the PBMs by Medicaid programs, except for a fixed administrative fee. The total reimbursement amount will be determined by a survey of national average drug acquisition costs administered by the Department of Health & Human Services.
Legislation & Regulation
Pharmacist and Access to Medicines - MVP Act

AMCP Comment Letter on Accelerated Approval and Considerations for Determining Whether a Confirmatory Trial is Underway

In AMCP's latest comments to the FDA, we emphasize the need for standardized public reporting of confirmatory trial progress, ensuring payers and health care providers have the necessary data to make informed coverage decisions. By supporting proactive communication and rigorous confirmatory trials, AMCP aims to balance early access to innovative treatments with patient safety and long-term therapeutic value.
Quality of Care, Legislation & Regulation, Coverage Parity, Drug Utilization Review (DUR)